Optimal management of cervical cancer in HIV‐positive patients: a systematic review
Open Access
- 1 July 2015
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 4 (9) , 1381-1393
Abstract
The clinical management of cervical cancer in HIV‐positive patients has challenges mainly due to the concerns on immune status. At present, their mode of management is similar to HIV‐seronegative patients involving the use of chemotherapy and radiotherapy concurrently as indicated. HIV infection, cancer, radiotherapy, and chemotherapy lower immunity through reduction in CD4 cell counts. At present there are no treatment guidelines for HIV‐positive patients. This study was done to systematically review the literature on cervical cancer management in HIV‐positive patients and treatment outcomes. A systematic literature search was done in the major databases to identify studies on the management of HIV‐positive patients with cervical cancer. Identified studies were assessed for eligibility and inclusion in the review following the guidelines of The Cochrane Handbook for Systematic Reviews and CRD's (Centre for Reviews and Dissemination) guidance for undertaking reviews in health care. Eight eligible studies were identified from the literature. Three of them were prospective while five were retrospective studies. Notably, the average age at diagnosis of cervical cancer in HIV‐positive patients was a decade lower than in seronegative patients. There was no difference in distribution of stages of disease at presentation between HIV‐positive and negative patients. Mild acute toxicity (Grades 1 and 2) was higher in HIV‐positive patients than in HIV‐negative patients in hematopoietic system. In the grades 3 and 4 reactions, anemia was reported in 4% versus 2% while gastrointestinal reactions were reported in 5% versus 2% respectively. In general, patients who were started early on HAART had higher rates of treatment completion. The study supports the suggestion that HAART should be commenced early at cervical cancer diagnosis in HIV‐positive patients diagnosed with cervical cancer to ensure less toxicity and better treatment compliance.Keywords
This publication has 37 references indexed in Scilit:
- A Six-Year Study of the Clinical Presentation of Cervical Cancer and the Management Challenges Encountered at a State Teaching Hospital in Southeast NigeriaClinical Medicine Insights: Oncology, 2013
- HPV: The global burdenNature, 2012
- Completion of and early response to chemoradiation among human immunodeficiency virus (HIV)‐positive and HIV‐negative patients with locally advanced cervical carcinoma in South AfricaCancer, 2011
- Worldwide burden of cervical cancer in 2008Annals of Oncology, 2011
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Reducing Uncertainties About the Effects of Chemoradiotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data From 18 Randomized TrialsJournal of Clinical Oncology, 2008
- Extensive subcutaneous metastasis from squamous cell carcinoma of the cervix in patient with HIVInternational Journal of Gynecological Cancer, 2008
- Human Resources for Treating HIV/AIDS: Needs, Capacities, and GapsAIDS Patient Care and STDs, 2007
- HIV impact on acute morbidity and pelvic tumor control following radiotherapy for cervical cancerGynecologic Oncology, 2006
- Incidence, mortality and survival in cancer of the cervix in Bangalore, IndiaBritish Journal of Cancer, 1995